Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
Feb. 11 --With an effective date about a month away, some doctor groups are cautious about how a new Centers for Medicare & Medicaid Services policy on the release of Medicare payment data will impact members.
“We'll have to wait to see how CMS uses this new authority,” Reid Blackwelder, president of the American Academy of Family Physicians, told Bloomberg BNA. “Our hope is that researchers use this data to understand and improve how health care dollars are spent.”
In a Jan. 17 notice, the CMS said it would begin to institute a new policy for releasing data on how much Medicare is reimbursing individual doctors (79 Fed. Reg. 3,205) . The agency said it will make individual determinations under the Freedom of Information Act (FOIA), weighing the privacy interest of the individual against the public interest.
Under its “Modified Policy on Freedom of Information Act Disclosure of Amounts Paid to Individual Physicians Under the Medicare Program,” which takes effect March 18, the CMS said it would use a FOIA exemption when it receives such a request (25 MCR 69, 1/17/14).
The previous policy, which had been based on court orders, was that the public interest was insufficient under FOIA to allow the disclosure of amounts that Medicare pays to individual physicians.
The CMS was legally barred from disclosing identifiable annual Medicare reimbursement payments of individual physicians or disclosure of payments in a manner that could identify individual physicians.
The new policy, delivered in a short notice sparse of operational detail, said the agency will start making case-by-case determinations as to whether FOIA's “exemption 6” applies to a given request for information. Exemption 6 requires CMS to weigh the balance between the privacy interest of individual physicians and the public interest in disclosure of such information.
“As the outcome of the balancing test will depend on the circumstances, the outcomes of these analyses may vary depending on the facts of each case,” the CMS said.
Anders M. Gilberg, senior vice president of government affairs at the Medical Group Management Association, called the notice “ambiguous” and said the CMS failed to make clear the standards it will use to evaluate data requests.
“MGMA has always supported the release of meaningful cost and quality data to benefit Medicare beneficiaries, but using an exemption in FOIA to release raw claims data without clear safeguards raises privacy concerns and may lead to its misuse,” he told Bloomberg BNA.
American Medical Association President Ardis Dee Hoven, in a statement, urged that physician payment information be released only for efforts aimed at improving the quality of health care services and with appropriate safeguards.
Both doctors and patients could be “unfairly impacted,” she said, by “the unfettered release of raw data” which could “result in inaccurate and misleading information.” She added that “the disclosure of payment data from government health care programs must be balanced against the confidentiality and personal privacy interests of physicians and patients.”
The data release saga reached a turning point in May 2013 when a federal court vacated a 33-year-old injunction that had foreclosed the government from releasing any Medicare physician reimbursement data that would identify specific physicians (24 MCR 669, 6/7/13).
The CMS subsequently asked for public comment about developing a new policy, stating that it has been receiving “multiple requests from various stakeholders for physician payment and reimbursement data.”
The agency had said it recognizes the role data can play in “achieving the common goal of better quality health care at lower costs.”
In one of the comments, about 80 state and national medical groups offered the operational details and protections they wanted to see in a new policy.
“Given the potential for security breaches, hackers, or efforts to re-identify information, we urge CMS to consider the potential impact of any data release on patient privacy and engage with experienced data statisticians, physician organizations, and other relevant stakeholders on ways to further protect such data,” according to one of the points in the five-page letter.
The signatories said they supported efforts that increase knowledge about the quality of care and the efficient use of resources, but also warned against allowing “untrained entities that lack knowledge about the Medicare program to attempt to detect fraud and abuse.”
In addition, “raw Medicare claims data is a crude metric for assessing the quality of medical care,” they said. “When used in isolation this data ignores the more important clinical factors that affect patients, including case mix, co-morbidities, and other patient characteristics.”
Although cautious, Blackwelder was optimistic about the new policy.
“If used correctly, the data can provide accurate and meaningful information to patients, physicians, and other stakeholders that can improve quality at the point of care,” he said. For example, it could be used to track billing for certain preventive services such as flu vaccinations.
The AAFP president said that CMS's new policy is not a “wholesale, cookie-cutter approach to releasing data and will weigh the privacy interests of individual physicians with the public interest in disclosure of payment information.”
Instead, he continued, it “ensures that CMS will evaluate each request rather than establish a universal protocol that risks inappropriate release of data.”
To contact the reporter on this story: Mindy Yochelson in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Ward Pimley at email@example.com
The CMS January notice is at http://www.gpo.gov/fdsys/pkg/FR-2014-01-17/pdf/2014-00808.pdf.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).